Skip to content

Opening book details…

About this Medicine article

Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801) by Castellano, Daniel; Capdevila, Jaume; Sastre, Javier; Alonso, Vicente; Llanos, Marta; García-Carbonero, Rocío; Manzano Mozo, José Luis; Sevilla, Isabel; Durán, Ignacio; Salazar, Ramón is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Castellano, Daniel; Capdevila, Jaume; Sastre, Javier; Alonso, Vicente; Llanos, Marta; García-Carbonero, Rocío; Manzano Mozo, José Luis; Sevilla, Isabel; Durán, Ignacio; Salazar, Ramón
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
Published
2013
Language
EN
Field
Medicine (Health Sciences)

More by Castellano, Daniel; Capdevila, Jaume; Sastre, Javier; Alonso, Vicente; Llanos, Marta; García-Carbonero, Rocío; Manzano Mozo, José Luis; Sevilla, Isabel; Durán, Ignacio; Salazar, Ramón

Browse all works by Castellano, Daniel; Capdevila, Jaume; Sastre, Javier; Alonso, Vicente; Llanos, Marta; García-Carbonero, Rocío; Manzano Mozo, José Luis; Sevilla, Isabel; Durán, Ignacio; Salazar, Ramón